MED12 and neoplasm: Consistent with our previous study in which 22 matched tumor and normal pairs of human PT were whole-exome sequenced15, the patient’s tumor, xenograft, and cell line harbored mutations in MED12, TP53, RB1, and KMT2D. The MPT-S1 model may be useful for future studies on PT biology and therapy.